Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
1989-6-16
|
pubmed:abstractText |
The expression of the interleukin-2 (IL-2) receptor was studied in neoplastic cells derived from acute leukemias, T-cell lymphoblastic lymphomas, peripheral T-cell lymphomas, chronic lymphocytic leukemias, well-differentiated lymphocytic lymphomas, and established cell lines by both flow cytometric analysis and sodium dodecyl sulfate/polyacrylamide gel electrophoresis (SDS-PAGE) after affinity crosslinking of radiolabeled IL-2. Cells from most acute leukemias (19 of 22), irrespective of their subtype (T, common or nonlymphoid leukemias), as well as T-cell lymphoblastic lymphomas and peripheral T-cell lymphomas expressed only the p70-75 beta subunit of the IL-2 receptor. Cells from the more mature B-cell neoplasms, chronic lymphocytic leukemia, and well-differentiated lymphocytic lymphoma, expressed predominantly alpha beta IL-2 receptors (11 of 14). In contrast to these results, most cell lines established from hematopoietic malignancies do not express either chain of the IL-2 receptor. Further studies are necessary to determine the exact function of the IL-2R p70-75 beta subunit in immature hematopoietic cells, but its wide distribution throughout the hematopoietic system suggests that IL-2 may play a role in the early stages of hematopoiesis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0006-4971
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
73
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
N
|
pubmed:pagination |
1968-72
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2653467-Cell Line,
pubmed-meshheading:2653467-Cross-Linking Reagents,
pubmed-meshheading:2653467-Humans,
pubmed-meshheading:2653467-Interleukin-2,
pubmed-meshheading:2653467-Leukemia,
pubmed-meshheading:2653467-Leukemia, Lymphocytic, Chronic, B-Cell,
pubmed-meshheading:2653467-Leukemia-Lymphoma, Adult T-Cell,
pubmed-meshheading:2653467-Lymphoma,
pubmed-meshheading:2653467-Phenotype,
pubmed-meshheading:2653467-Receptors, Interleukin-2,
pubmed-meshheading:2653467-Recombinant Proteins
|
pubmed:year |
1989
|
pubmed:articleTitle |
Expression of interleukin-2 receptor beta subunit in hematopoietic malignancies.
|
pubmed:affiliation |
Pediatric Branch, NCI, Bethesda, MD 20892.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|